Results 201 to 210 of about 150,574 (342)

Intranodal thyroid inclusions revisited: a morphological analysis and application of BRAF VE1 immunohistochemistry

Histopathology, Volume 86, Issue 6, Page 878-890, May 2025.
In this study, we highlight the underrecognized phenomenon of intranodal thyroid inclusions coexisting with metastatic papillary thyroid carcinoma (PTC) within the same lymph node. The thyroid inclusions may appear cytologically bland (A‐D) or show various degrees of nuclear changes (E‐H).
Yu‐Che Chuang, Ying‐Ju Kuo, Jen‐Fan Hang   +2 more
wiley   +1 more source

Papillary Thyroid Carcinoma Infiltrating a Parathyroid Adenoma: A Case Report. [PDF]

Cureus
McLuckie A, Thornton SB, Andree R, O'Neil S.   +3 more
europepmc   +1 more source

Bridging Cancer and COVID‐19: The Complex Interplay of ACE2 and TMPRSS2

Cancer Medicine, Volume 14, Issue 7, April 2025.
ACE2 and TMPRSS2 not only mediate SARS‐CoV‐2 infection may also be involved in cancer progression (such as affecting tumor proliferation, matastasis or immune infiltration), and they can be used as targets to treat cancer patients infected with SARS‐CoV‐2.
Xuerui Tang, Liuzhi Lu, Xiaoping Li, Panpan Huang   +3 more
wiley   +1 more source

Papillary Thyroid Carcinoma With 5 Unique Point Mutations and Typical Behavior. [PDF]

JCEM Case Rep
Chauhan A, Sen S, Amin K, Burmeister LA.
europepmc   +1 more source

Mixed Medullary-Follicular Carcinoma and Papillary Carcinoma of the Same Thyroid.

, 1998
Chung-Jung Wu, Hsiang-Ling Chen, Yuh-Min Song, Wayne Huey‐Herng Sheu, Shin-Ho CHEN   +4 more
openalex   +2 more sources

The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis

Cancer Medicine, Volume 14, Issue 8, April 2025.
NLRP1, a key component of the inflammasome complex, has emerged as a significant factor in cancer development. Through a systematic in silico study, we observed NLRP1 dysregulation in multiple tumor types, with significant correlations to survival outcomes, cancer‐associated fibroblast infiltration, and drug sensitivity, highlighting its potential as a
Leila Habibipour, Mahboubeh Sadeghi, Alireza Raghibi, Nima Sanadgol, Amirhossein Mohajeri Khorasani, Pegah Mousavi   +5 more
wiley   +1 more source

Papillary thyroid carcinoma: an interesting case report. [PDF]

Pan Afr Med J
Kalode S, Ghewade P, Tekulwar P.
europepmc   +1 more source

Occult Papillary Thyroid Carcinoma in Hashimoto's Thyroiditis Presenting as a Metastatic Bone Tumor.

, 1998
Mitsushige Nishikawa, Nagaoki Toyoda, Toshinaga Yonemoto, Atsuko Fujiyama, YOSHIFUMI OGAWA, Toshiko Tokoro, Noriko Sakaguchi, Masayoshi Yoshimura, Noriko Yoshikawa, Sakuyoshi Tabata, Hirofumi Kumazawa, Toshio Yamashita, Noriko Sakaida, Akiharu Okamura, K Kasagi, Mitsuo Inada   +15 more
openalex   +2 more sources

Prevalence and Distribution of ret/ptc 1, 2, and 3 in Papillary Thyroid Carcinoma in New Caledonia and Australia1 [PDF]

, 2000
Elizabeth L. Chua, Wan Man Wu, Kim Tran, Stanley W. McCarthy, Christopher S. Lauer, Dominique Dubourdieu, Nicholas Packham, Christopher J. O’Brien, John R. Turtle, Qihan Dong   +9 more
openalex   +1 more source

The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression

Cancer Medicine, Volume 14, Issue 7, April 2025.
ABSTRACT Inhibitor of differentiation 4 (ID4) is a highly conserved DNA‐binding inhibitory protein of mammals, and its main role is to bind basic helix–loop–helix (b‐HLH) so that it loses its DNA‐binding activity, which in turn regulates the transcription of key genes, regulating cell differentiation and proliferation as the physiological function ...
Yuhang Song, Panshi Zhang, Sudhanshu Bhushan, Xinhong Wu, Hongmei Zheng, Yalong Yang   +5 more
wiley   +1 more source